Project Grant 2213156

Award Date 9/15/22
Completion Date 8/31/24
Dollars Obligated $256K
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75230, USA
Similar Awards
This $1,199,991 Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program aims to develop novel technologies for real-time assessment of blood clot properties to improve stroke treatment. The key products and services under this grant include: Integration of a sub-millimeter Raman fiber probe into a catheter for intravascular, in-vivo measurement of clot chemical composition. Training of a convolutional neural network to...
This Project Grant award, totaling $2,130,388.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award aims to improve understanding of why some stroke patients have poor outcomes despite successful recanalization (reopening of blocked blood vessels). The key products and services to be delivered include: Developing a longitudinal...
This $498,995 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports the development of a highly parallelized interferometric near-infrared spectroscopy (INIRS) platform for the real-time, non-invasive measurement of cerebral blood flow. The research aims to address the limitations of current stroke diagnosis and monitoring techniques...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $619,969 to The Methodist Hospital Research Institute (HMRI) to develop the DEEPSTROKE+ augmented-intelligence framework for improved stroke triage and diagnosis. The project aims to create a mobile AI-powered diagnostic tool to enhance identification and triage of stroke...
This Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a Fused Imaging and Large Language Foundational Model (FILLM) to predict 90-day outcomes for acute ischemic stroke patients. The $124,485 award, effective from February 1, 2025 to January 31, 2027, will be used by The Leland Stanford Junior University to integrate...
The National Science Foundation (NSF) awarded a $274,970 Small Business Innovation Research (SBIR) Phase I grant to Censyn, Inc. on November 15, 2023 under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The award is for the development of a portable, handheld electroencephalogram (EEG) device designed to provide a rapid, quantifiable assessment of concussions and facilitate faster access to proper patient care. The project aims to overcome limitations of current...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,340,263 to Emory University to develop machine learning models that can predict post-stroke cognitive impairment (PSCI) using routine clinical and imaging data. The project aims to: Learn to predict PSCI using large retrospective datasets of electronic health records and neuroimaging data. Adapt and validate the predictive models using a smaller prospective dataset with more...
This three-year, $4.62 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program. The Johns Hopkins University will develop a digital biomarker to predict conversion from transient post-stroke cognitive impairment to persistent vascular cognitive impairment using functional brain network signals derived from magnetoencephalography and electroencephalography data. Researchers will collect MEG...
This $490,049 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research by Shearit LLC to evaluate the efficacy of their Lamiflo drug for reducing ischemic penumbra and core volumes in acute ischemic stroke. The 1-year study will test Lamiflo, a drag-reducing polymer that enhances blood flow, in rat models of middle cerebral artery...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant of $275,000 awarded to Xtract Medical Inc. aims to develop and demonstrate the feasibility of a novel catheter-based system for improved removal of blood clots during mechanical thrombectomy procedures to treat venous thromboembolism (VTE). The proposed system is designed to effectively remove large blood clots while minimizing damage to blood vessels and reducing complications such as...

SBIR PHASE I: PRE-HOSPITAL DETECTION OF LARGE VESSEL OCCLUSION STROKES -THE BROADER IMPACT/COMMERCIAL POTENTIAL OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT IS TO ARM EMERGENCY PERSONNEL WITH AN OBJECTIVE TOOL FOR IDENTIFYING LARGE VESSEL OCCLUSION (LVO) STROKES WHILE IN ROUTE TO THE HOSPITAL. THIS RAPID AND ACCURATE TRIAGE OF STROKE WILL ENABLE ROUTING OF PATIENTS TO THE MOST APPROPRIATE CARE SETTING AND REDUCE THE TIME TO INTERVENTION. LVOS REQUIRE ENDOVASCULAR THERAPY WHICH ONLY COMPREHENSIVE STROKE CENTERS HAVE THE CAPABILITY TO CONDUCT. IF A PATIENT WITH AN LVO IS ROUTED TO A HOSPITAL WITHOUT ENDOVASCULAR CAPABILITIES SIMPLY BECAUSE IT WAS CLOSER, THE TIME TO INTERVENTION IS EXTENDED DRASTICALLY. WHEN IT COMES TO IMPROVING OUTCOMES, TIME TO OPTIMAL INTERVENTION IS THE MOST IMPORTANT FACTOR WITH THE BEST OUTCOMES ACHIEVED UNDER THREE HOURS AND STATISTICALLY SIGNIFICANT IMPROVEMENTS FOR EACH 15-MINUTE WINDOW UNDER THAT THRESHOLD. STROKE IS THE SECOND LEADING CAUSE OF DEATH AND THE PRIMARY CAUSE OF LONG-TERM DISABILITY WORLDWIDE COSTING THE US $65B EVERY YEAR. NEARLY 800,000 PEOPLE SUFFER A STROKE IN THE US ANNUALLY AND 40% ARE LEFT WITH A PERMANENT DISABILITY. THE PROJECT WILL STREAMLINE STROKE TRIAGE IN THE PRE-HOSPITAL SETTING TO REDUCE TIME TO INTERVENTION AND IMPROVE OUTCOMES IN STROKE PATIENTS. THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT AN EEG-BASED PRODUCT FOR EMS WORKERS TO USE IN THE PRE-HOSPITAL SETTING FOR THE FAST AND OBJECTIVE DIAGNOSIS OF LVO IN SUSPECTED STROKE PATIENTS. IN UNDER FIVE MINUTES, EMS WORKERS WILL BE ABLE TO DEPLOY, COLLECT DATA, AND HAVE THE ANALYZED RESULTS PRESENTED IN AN INTUITIVE DASHBOARD IDENTIFYING THE PROBABILITY OF AN LVO, ENABLING EMS WORKERS TO ROUTE PATIENTS TO STROKE CENTERS WITH EVT CAPABILITIES. WHEN A PATIENT ARRIVES AT THE HOSPITAL, THE DETERMINATION MADE WITHIN THE AMBULANCE WILL BE CONVEYED TO PHYSICIANS WHO CAN THEN IMMEDIATELY START INTERVENTION, REDUCING THE TIME FROM ONSET TO INTERVENTION AND IMPROVING SHORT AND LONG-TERM PATIENT OUTCOMES. COMPREHENSIVE HISTORICAL DATASETS OF EEG-DATA FROM STROKE PATIENTS USING A BROAD ARRAY OF HARDWARE WILL BE USED TO DEVELOP A MACHINE LEARNING MODEL THAT CAN CLASSIFY PATIENTS INTO LVO VS NON-LVO STROKE AND STROKE VS NON-STROKE. AUTOMATION OF DATA CLEANING AND FEATURE EXTRACTION WILL ENABLE A HIGHLY USER-FRIENDLY EXPERIENCE AND THE REQUIRED WORKFLOW INTEGRATION FOR OUR END-USERS, EMERGENCY MEDICAL TECHNICIANS. LASTLY, THIS MODEL WILL BE VALIDATED WITH NOVEL EEG DATA COLLECTED AT TWO CLINICAL SITES, LAYING THE FOUNDATION FOR REGULATORY INTERACTIONS. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.

Posted 9/8/22, 12:00 AM